IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.380
0.00 (0.00%)
At close: Nov 6, 2024, 4:00 PM
0.396
+0.016 (4.11%)
After-hours: Nov 6, 2024, 7:59 PM EST
IGC Pharma Employees
IGC Pharma had 67 employees as of March 31, 2024. The number of employees increased by 6 or 9.84% compared to the previous year.
Employees
67
Change (1Y)
6
Growth (1Y)
9.84%
Revenue / Employee
$15,851
Profits / Employee
-$198,552
Market Cap
28.74M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bionano Genomics | 344 |
| Precision Optics Corporation | 85 |
| Spectral AI | 78 |
| BioXcel Therapeutics | 74 |
| MiNK Therapeutics | 31 |
| Movano | 30 |
| NeuroOne Medical Technologies | 16 |
| Iterum Therapeutics | 14 |
IGC News
- 20 hours ago - IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer's and Weight Loss Therapies - Accesswire
- 20 days ago - IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1 - Accesswire
- 4 weeks ago - IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge - Accesswire
- 7 weeks ago - IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment - Business Wire
- 2 months ago - IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease - Business Wire
- 2 months ago - IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease - Business Wire
- 3 months ago - IGC Pharma Reports First Quarter Fiscal 2025 Results - Business Wire
- 3 months ago - IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target - Business Wire